ANTICARDIOLIPIN - ANVISA Registration 10280220197

Access comprehensive regulatory information for ANTICARDIOLIPIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10280220197 and manufactured by HEMAGEN DIAGNOSTICS INC.. The registration is held by HEMAGEN DIAGNOSTICOS COMERCIO IMP E EXPORTACAO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, PHADIA AB, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.